ArticleAIDS research and therapy2020

Efficacy and safety of abacavir/lamivudine plus rilpivirine as a first-line regimen in treatment-naïve HIV-1 infected adults.

Sharlene Ho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.